We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
+20.67%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$359M
AUM Growth
+$22.8M
Cap. Flow
-$158K
Cap. Flow %
-0.04%
Top 10 Hldgs %
58.31%
Holding
131
New
16
Increased
29
Reduced
30
Closed
17
Avg Time Held
4.3 quarters
Top 10 Avg Time Held
4.1 quarters
Top 20 Avg Time Held
4.6 quarters

Top Buys

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$2.71M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$1.99M
3
RCKT icon
Rocket Pharmaceuticals
RCKT
+$1.98M
4
PLTR icon
Palantir
PLTR
+$1.69M
5
UAA icon
Under Armour
UAA
+$1.53M

Top Sells

Rank Stock Value
1
ARGX icon
argenx
ARGX
+$4.04M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.32M
3
GPN icon
Global Payments
GPN
+$2.26M
4
XYZ icon
Block Inc
XYZ
+$2.21M
5
HTZWW icon
Hertz Global Holdings Warrants
HTZWW
+$1.65M

Sector Composition

Rank Sector Weight
1 Healthcare 28.92%
2 Technology 25.58%
3 Communication Services 17.05%
4 Consumer Discretionary 16.61%
5 Miscellaneous 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SPOT icon
1
Spotify
SPOT
$108B
$40.1M 11.18%
213,000
-3,000
-1% -$524K
2021 Q4
8 quarters
SHOP icon
2
Shopify
SHOP
$227B
$31.4M 8.74%
415,000
– –
2021 Q4
8 quarters
TSLA icon
3
Tesla
TSLA
$1.48T
$29.4M 8.19%
118,300
+5,300
+5% +$1.26M
2022 Q4
4 quarters
SNOW icon
4
Snowflake
SNOW
$126B
$24.9M 6.93%
129,000
– –
2021 Q4
8 quarters
AMZN icon
5
Amazon
AMZN
$2.79T
$21.3M 5.92%
141,000
– –
2022 Q3
5 quarters
OXY.WS icon
6
Occidental Petroleum Corp Warrants
OXY.WS
$37.3B
$18.9M 5.28%
496,207
-18,000
-4% -$705K
2021 Q4
8 quarters
IONS icon
7
Ionis Pharmaceuticals
IONS
$7.04B
$11.5M 3.2%
217,493
-11,000
-5% -$527K
2021 Q4
8 quarters
PRQR icon
8
ProQR Therapeutics
PRQR
$209M
$11.1M 3.1%
5,344,446
– –
2021 Q4
8 quarters
ROKU icon
9
Roku
ROKU
$22.7B
$10.8M 3%
120,000
+10,000
+9% +$836K
2023 Q2
2 quarters
MRK icon
10
Merck
MRK
$350B
$9.96M 2.78%
87,978
– –
2021 Q4
8 quarters
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.33T
$9.67M 2.69%
70,000
-5,000
-7% -$672K
2021 Q4
8 quarters
ARWR icon
12
Arrowhead Research
ARWR
$8.21B
$8.49M 2.37%
273,936
+14,900
+6% +$396K
2021 Q4
8 quarters
RARE icon
13
Ultragenyx Pharmaceutical
RARE
$1.47B
$8.02M 2.23%
166,506
+51,265
+44% +$1.99M
2021 Q4
8 quarters
DDOG icon
14
Datadog
DDOG
$102B
$7.79M 2.17%
65,993
+3,500
+6% +$361K
2022 Q4
4 quarters
PLTR icon
15
Palantir
PLTR
$501B
$7.13M 1.99%
425,000
+95,000
+29% +$1.69M
2023 Q2
2 quarters
RCKT icon
16
Rocket Pharmaceuticals
RCKT
$252M
$6.87M 1.92%
233,050
+89,700
+63% +$1.98M
2022 Q2
6 quarters
ITCI icon
17
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.62M 1.85%
93,983
+333
+0.4% +$19.2K
2023 Q2
2 quarters
ZLAB icon
18
Zai Lab
ZLAB
$2.59B
$6.27M 1.75%
240,683
– –
2021 Q4
8 quarters
VRTX icon
19
Vertex Pharmaceuticals
VRTX
$123B
$6.21M 1.73%
15,116
-6,279
-29% -$2.32M
2021 Q4
8 quarters
NET icon
20
Cloudflare
NET
$124B
$5.95M 1.66%
75,000
– –
2021 Q4
8 quarters
MSFT icon
21
Microsoft
MSFT
$4.04T
$5.93M 1.65%
16,000
– –
2023 Q1
3 quarters
AXSM icon
22
Axsome Therapeutics
AXSM
$8.19B
$5.55M 1.55%
72,032
– –
2023 Q1
3 quarters
MRNA icon
23
Moderna
MRNA
$86.3B
$4.93M 1.37%
43,861
– –
2022 Q1
7 quarters
SE icon
24
Sea Limited
SE
$58.8B
$4.64M 1.29%
118,000
+20,000
+20% +$816K
2023 Q2
2 quarters
ALNY icon
25
Alnylam Pharmaceuticals
ALNY
$29.9B
$4.23M 1.18%
21,693
+1,670
+8% +$284K
2023 Q3
1 quarter
1
2 3 4 5

Similar funds

RWMH
Riverpoint Wealth Management Holdings Chicago, Illinois $544M AUM 20.39% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $544M AUM 132.56% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $544M AUM 70.51% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $545M AUM 64.06% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
CCM
Coerente Capital Management Toronto, Ontario, Canada $543M AUM 7.53% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Privium Fund Management's Q4 2023 Portfolio in Review

As of Q4 2023, Privium Fund Management held 131 positions worth $359M, up 6.8% from $336M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Privium Fund Management's Q4 2023 filing shows 16 new, 29 increased, 30 reduced and 17 closed positions. Its largest new stake was Roivant Sciences: 277,795 shares worth $3.15M. The largest sale was argenx, an estimated $4.04M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 25% a quarter earlier, followed by Technology and Communication Services.

  • Privium Fund Management's largest Q4 2023 buy was Roivant Sciences: 277,795 shares worth $3.15M.
  • Privium Fund Management added most to Ultragenyx Pharmaceutical in Q4 2023, an estimated $1.99M increase.
  • Privium Fund Management's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $2.32M.
  • Privium Fund Management fully exited argenx in Q4 2023, selling an estimated $4.04M.
  • Privium Fund Management's ten largest holdings make up 58% of its $359M portfolio in Q4 2023.
  • Privium Fund Management opened 16 new positions and closed 17 in Q4 2023.
  • Privium Fund Management's portfolio value rose 6.8% quarter-over-quarter to $359M.

Based on Privium Fund Management's 13F filing for Q4 2023, filed 13 Feb 2024.